DE69110875D1 - Azacyclische oder azabicyclische verbindungen, ihre darstellung und anwendung. - Google Patents

Azacyclische oder azabicyclische verbindungen, ihre darstellung und anwendung.

Info

Publication number
DE69110875D1
DE69110875D1 DE69110875T DE69110875T DE69110875D1 DE 69110875 D1 DE69110875 D1 DE 69110875D1 DE 69110875 T DE69110875 T DE 69110875T DE 69110875 T DE69110875 T DE 69110875T DE 69110875 D1 DE69110875 D1 DE 69110875D1
Authority
DE
Germany
Prior art keywords
azacyclic
representation
application
compounds
azabicyclic compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69110875T
Other languages
English (en)
Other versions
DE69110875T2 (de
Inventor
John Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE69110875D1 publication Critical patent/DE69110875D1/de
Application granted granted Critical
Publication of DE69110875T2 publication Critical patent/DE69110875T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69110875T 1990-03-21 1991-03-20 Azacyclische oder azabicyclische verbindungen, ihre darstellung und anwendung. Expired - Fee Related DE69110875T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK072790A DK72790D0 (da) 1990-03-21 1990-03-21 Heterocycliske forbindelser, deres fremstilling og anvendelse
PCT/DK1991/000087 WO1991014686A1 (en) 1990-03-21 1991-03-20 Azacyclic or azabicyclic compounds, their preparation and use

Publications (2)

Publication Number Publication Date
DE69110875D1 true DE69110875D1 (de) 1995-08-03
DE69110875T2 DE69110875T2 (de) 1996-03-21

Family

ID=8096852

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69110875T Expired - Fee Related DE69110875T2 (de) 1990-03-21 1991-03-20 Azacyclische oder azabicyclische verbindungen, ihre darstellung und anwendung.

Country Status (18)

Country Link
US (1) US5182283A (de)
EP (1) EP0521067B1 (de)
JP (2) JPH05505811A (de)
AT (1) ATE124409T1 (de)
AU (1) AU660609B2 (de)
CA (1) CA2078791A1 (de)
DE (1) DE69110875T2 (de)
DK (2) DK72790D0 (de)
ES (1) ES2074714T3 (de)
FI (1) FI924190A0 (de)
GR (1) GR3017434T3 (de)
IE (1) IE71515B1 (de)
IL (1) IL97611A (de)
NO (1) NO304790B1 (de)
NZ (1) NZ237475A (de)
PT (1) PT97099B (de)
WO (1) WO1991014686A1 (de)
ZA (1) ZA912122B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201749D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Plc Medicaments
WO1997017955A1 (en) * 1995-11-13 1997-05-22 Eli Lilly And Company Method for treating anxiety

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048031A1 (de) * 1979-12-21 1981-09-17 Firmenich S.A., 1211 Genève Verfahren zur herstellung substituierter pyrazine
US4859775A (en) * 1985-10-01 1989-08-22 Philip Morris Incorporated Process for preparing acylpyrazine ethers
JPS6431779A (en) * 1987-07-28 1989-02-02 Hokuriku Pharmaceutical Pyrazine derivative
IL88846A0 (en) * 1988-01-08 1989-07-31 Merck Sharp & Dohme Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
NZ227684A (en) * 1988-01-30 1991-07-26 Merck Sharp & Dohme Pyrazine, pyridazine, and pyrimidine derivatives and pharmaceutical compositions
JPH02138179A (ja) * 1988-11-17 1990-05-28 Daiso Co Ltd 電荷移動錯体とその製造法
GB8918060D0 (en) * 1989-08-08 1989-09-20 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
AU660609B2 (en) 1995-07-06
FI924190A (fi) 1992-09-18
NO923646L (no) 1992-09-21
ES2074714T3 (es) 1995-09-16
WO1991014686A1 (en) 1991-10-03
NO923646D0 (no) 1992-09-18
DE69110875T2 (de) 1996-03-21
JP2000344765A (ja) 2000-12-12
JPH05505811A (ja) 1993-08-26
EP0521067A1 (de) 1993-01-07
NO304790B1 (no) 1999-02-15
US5182283A (en) 1993-01-26
IL97611A (en) 1997-06-10
IE71515B1 (en) 1997-02-12
GR3017434T3 (en) 1995-12-31
ATE124409T1 (de) 1995-07-15
NZ237475A (en) 1993-11-25
IE910863A1 (en) 1991-09-25
EP0521067B1 (de) 1995-06-28
DK0521067T3 (da) 1995-11-06
IL97611A0 (en) 1992-06-21
PT97099A (pt) 1991-12-31
ZA912122B (en) 1991-12-24
AU7574491A (en) 1991-10-21
FI924190A0 (fi) 1992-09-18
DK72790D0 (da) 1990-03-21
CA2078791A1 (en) 1991-09-22
PT97099B (pt) 1998-08-31

Similar Documents

Publication Publication Date Title
ATE174027T1 (de) Heterozyklische verbindungen, ihre herstellung und anwendung
DE69414554T2 (de) Heterocyclische verbindungen und ihre herstellung und verwendung
DE69128145T2 (de) 1,2,5,6-tetrahydro-1-methylpyridine, ihre herstellung und anwendung
FI954131A (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
ATE130611T1 (de) Heterozyklische verbindungen, ihre herstellung und anwendung.
DE69110875D1 (de) Azacyclische oder azabicyclische verbindungen, ihre darstellung und anwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee